Diagnosis of Tuberculosis in Swiss Children
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Mycobacterium Tuberculosis
- Tuberculosis
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 17 years
- Gender
- Both males and females
Description
This will be done by measuring a variety of parameters in the blood samples and compare them with the current diagnostic gold standard for TB or for culture/NAAT non-confirmed TB cases a consensus case definition is used. Currently available immunodiagnostic tests (IGRA/TST) will be compared to nove...
This will be done by measuring a variety of parameters in the blood samples and compare them with the current diagnostic gold standard for TB or for culture/NAAT non-confirmed TB cases a consensus case definition is used. Currently available immunodiagnostic tests (IGRA/TST) will be compared to novel immunodiagnostic tests which will include: several novel, additional M. tuberculosis-specific Antigens cytokines that are highly expressed Since there is no diagnostic gold standard for TB infection we will rely on a clinical composite reference standard for diagnosing TB infection. Biomarkers will be determined by: including M. tuberculosis-specific antigens that are specifically expressed in either TB infection or disease, measuring phenotypes and cytokine production of M. tuberculosis-specific cells.
Tracking Information
- NCT #
- NCT03044509
- Collaborators
- Ospedale Regionale Bellinzona e Valli
- University Hospital Inselspital, Berne
- University of Lausanne Hospitals
- University Hospital, Geneva
- Luzerner Kantonsspital
- Cantonal Hospital of St. Gallen
- University Children's Hospital, Zurich
- Kantonsspital Aarau
- Investigators
- Principal Investigator: Nicole Ritz, PD Dr med UKBB